Should we abandon hormonal therapy in endometrial cancer? Outcomes of recurrent and metastatic endometrial cancer treated with systemic progestins

PURPOSE: The objective of this study is to determine primary survival endpoints in women with recurrent and metastatic endometrial carcinoma (RMEC) treated with progestins. METHODS: A retrospective chart review was conducted at The Ottawa Hospital using electronic medical records. Inclusion criteria...

Descripción completa

Detalles Bibliográficos
Autores principales: Kulkarni, A., Wright, N. M. Andrews, Forget, A. N., Ramsay, T., Mallick, R., Weberpals, J. I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469659/
https://www.ncbi.nlm.nih.gov/pubmed/37417528
http://dx.doi.org/10.1002/cam4.6276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469659/
https://www.ncbi.nlm.nih.gov/pubmed/37417528
http://dx.doi.org/10.1002/cam4.6276

Ejemplares similares